Human papillomavirus knowledge and awareness among undergraduates in healthcare training in New Zealand

New Zealand Medical Journal

Volumn 122, Issue 1304, 2009, Pages 33-45

  Chelimo, Carol ^a   Wouldes, Trecia A ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; AWARENESS; FEMALE; HEALTH CARE; HUMAN; MALE; MEDICAL EDUCATION; NEW ZEALAND; QUESTIONNAIRE; SCREENING TEST; SEX DIFFERENCE; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; UTERINE CERVIX CANCER; VIRUS INFECTION; VIRUS TRANSMISSION; WART VIRUS;

ADOLESCENT; CHILD; CONDYLOMATA ACUMINATA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; MALE; NEW ZEALAND; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; QUESTIONNAIRES; SEXUALLY TRANSMITTED DISEASES, VIRAL; STUDENTS, HEALTH OCCUPATIONS; YOUNG ADULT;

EID: 70449512711     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. WHO. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Human Papillomaviruses. IARC Monographs. 2007;90.
2. Bosch FX, de Sanjosé S. The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers. 2007;23(4):213-227 (Pubitemid 47015785)
3. WHO. Cancer, Fact sheet No 297. 2006 [updated February; cited 2008 1 June]. Available from: http://www.who.int/mediacentre/factsheets/fs297/en/index. html
4. NZHIS. Cancer: New Registrations and Deaths 2004. Wellington: New Zealand Health Information Service, Ministry of Health Contract; 2007.
5. Ault KA, Giuliano AR, Edwards RP, et al. A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine. Vaccine. 2004;22(23-24):3004- 3007 (Pubitemid 39037200)
6. Harper DM, Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet. 2004;364(9447):1757-1765 (Pubitemid 39488060)
7. Harper DM, Franco EL, Wheeler CM, et al. Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006;367(9518):1247-1255
8. Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med. 2002;347(21):1645-1651 (Pubitemid 35340782)
9. Mao C, Koutsky LA, Ault KA, et al. Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstet Gynecol. 2006;107(1):18-27. (Pubitemid 43755499)
10. Villa LL, Costa RLR, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005;6(5):271-278
11. Saslow D, Castle PE, Cox JT, et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin. 2007;57:7-28. (Pubitemid 46148088)
12. Speech notes for Helen Clark's announcement of the HPV Vaccine Programme. Manurewa: Manukau SuperClinic, Great South Road: The official website of the New Zealand government; 2008 [updated 2 May, 2008; cited 2008 May]. Available from: http://www.beehive.govt.nz/speech/announcement+hpv+vaccine+programme
13. New Zealand Human Papillomavirus (HPV) Immunization Programme. Wellington: Ministry of Health: Ministry of Health, New Zealand; 2008 [updated 18 September, 2008; cited 2009 October]. Available from: http://www.moh.govt.nz/ moh.nsf/indexmh/immunisationdiseasesandvaccines- hpv-programme
14. Johnston A, Fernando D, MacBride-Stewart G. Sexually transmitted infections in New Zealand in 2003. N Z Med J. 2005;118(1211). http://www.nzmj.com/journal/118-1211/1347
15. Yacobi E, Tennant C, Ferrante J, et al. University students' knowledge and awareness of HPV. Prev Med. 1999;28(6):535-541 (Pubitemid 29372480)
16. Lenselink CH, Schmeink CE, Melchers WJG, et al. Young adults and acceptance of the human papillomavirus vaccine. Public Health. 2008;122(12):1295-1301
17. Baer H, Allen S, Braun L. Knowledge of human papillomavirus infection among young adult men and women: implications for health education and research. J Community Health. 2000;25(1):67-78. (Pubitemid 30112206)
18. Lambert EC. College students' knowledge of human papillomavirus and effectiveness of a brief educational intervention. J Am Board Fam Pract. 2001;14(3):178-183
19. Hoover DR, Carfioli B, Moench EA. Attitudes of adolescent/young adult women toward human papillomavirus vaccination and clinical trials. Health Care Women Int. 2000;21(5):375-391
20. Philips Z, Johnson S, Avis M, Whynes DK. Human papillomavirus and the value of screening: young women's knowledge of cervical cancer. Health Educ Res. 2003;18(3):318-328 (Pubitemid 36749237)
21. McPartland TS, Weaver BA, Shu-Kuang L, Koutsky LA. Men's perceptions and knowledge of human papillomavirus (HPV) infection and cervical cancer. J Am Coll Health. 2005;53(5):225-230 (Pubitemid 40522511)
22. Dell DL, Chen H, Ahmad F, Stewart DE. Knowledge about human papillomavirus among adolescents. Obstet Gynecol. 2000;96(5 Pt 1):653-656
23. Di Giuseppe G, Abbate R, Liguori G, et al. Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. Br J Cancer. 2008;99(2):225-229
24. Gerend MA, Barley J. Human papillomavirus vaccine acceptability among young adult men. Sex Transm Dis. 2009;36(1):58-62.
25. Gerend MA, Magloire ZF. Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. J Adolesc Health. 2008;42(3):237-242
26. McClelland A, Liamputtong P. Knowledge and acceptance of human papillomavirus vaccination: perspectives of young Australians living in Melbourne, Australia. Sex Health. 2006;3(2):95-101.